DAFPUS IVIG SJS

SJS :

Toxic epidermal necrolysis and Stevens-Johnson syndrome

Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet
journal of rare diseases. 2010 Dec 16;5(1):1.

Steorid :

Role of systemic steroids in the outcome of Stevens-Johnson syndrome and toxic

epidermal necrolysis

Azfar NA, Zia MA, Malik LM, Khan AR, Jahangir M. Role of systemic steroids in the outcome
of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Pak Assoc Dermatol.
2010;20:158-62.

Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome

and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital,
Navamindradhiraj University, Bangkok

Roongpisuthipong W, Prompongsa S, Klangjareonchai T. Retrospective analysis of

corticosteroid treatment in Stevens-Johnson syndrome and/or toxic epidermal necrolysis over
a period of 10 years in Vajira Hospital, Navamindradhiraj University, Bangkok. Dermatology
research and practice. 2014 Jun 15;2014.

IVIG:

review of intravenous immunoglobulin in steven-johnson syndrome and ten

Momin SB. Review of Intravenous Immunoglobulin in the Treatment of Stevens-Johnson

Syndrome and Toxic Epidermal Necrolysis. J Clin Aesthet Dermatol. 2009 Feb;2(2):51-58.

Intravenous immunoglobulin therapy for Stevens-Johnson syndrome

Brett, A. S., Philips, D., & Lynn, A. W. (2001). Intravenous immunoglobulin therapy for
Stevens-Johnson syndrome. South Med J.. (2001).;94:342

Intravenous immunoglobulin in the treatment of StevensJohnson syndrome and

toxic epidermal necrolysis a meta-analysis with meta-regression of observational
studies

Barron, S. J., Del Vecchio, M. T. and Aronoff, S. C. (2015), Intravenous immunoglobulin in the
treatment of StevensJohnson syndrome and toxic epidermal necrolysis: a meta-analysis with
meta-regression of observational studies. Int J Dermatol, 54: 108115. doi:10.1111/ijd.12423
intravenous immunoglobulin treatment for SJS and TEN

Bachot N, Revuz J, Roujeau J. Intravenous Immunoglobulin Treatment for Stevens-Johnson

Syndrome and Toxic Epidermal Necrolysis: A Prospective Noncomparative Study Showing No
Benefit on Mortality or Progression. Arch Dermatol. 2003;139(1):33-36.
doi:10.1001/archderm.139.1.33

Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome

and toxic epidermal necrolysis: seven cases and review of the literature

Metry DW, Jung P, Levy ML. Use of intravenous immunoglobulin in children with Stevens-
Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature.
Pediatrics. 2003 Dec 1;112(6):1430-6.

Profile and Pattern of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

in a General Hospital in Singapore: Treatment Outcomes
Tan SK, Tay YK. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal
necrolysis in a general hospital in Singapore: treatment outcomes. Acta dermato-
venereologica. 2012 Jan 1;92(1):62-6.

Retrospective analysis of StevenseJohnson syndrome and toxic epidermal

necrolysis in 87 Japanese patients e Treatment and outcome
Yamane Y, Matsukura S, Watanabe Y, Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z,
Aihara M. Retrospective analysis of StevensJohnson syndrome and toxic epidermal
necrolysis in 87 Japanese patientsTreatment and outcome. Allergology International. 2016
Jan 31;65(1):74-81.